Randomized crossover trial on motor and non-motor outcome of directional deep 
brain stimulation in Parkinson's disease

Gharabaghi, A; Cebi, I; Leavitt, D; Scherer, M; Bookjans,; Bookjans, P; Brunnett, B; Milosevic , L; Weiss, D

doi:10.1038/s41531-024-00812-0

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Randomized crossover trial on motor and non-motor outcome of directional deep brain stimulation in Parkinson's disease

MPS-Authors

/persons/resource/persons303004

Leavitt, D
Department of Computational Neuroscience, Max Planck Institute for Biological Cybernetics, Max Planck Society;

External Resource

https://www.nature.com/articles/s41531-024-00812-0.pdf
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Gharabaghi, A., Cebi, I., Leavitt, D., Scherer, M., Bookjans, Bookjans, P., et al. (2024). Randomized crossover trial on motor and non-motor outcome of directional deep brain stimulation in Parkinson's disease. npj Parkinson's Disease, 10(1): 204. doi:10.1038/s41531-024-00812-0.

Cite as: https://hdl.handle.net/21.11116/0000-0010-02EB-3

Abstract

Deep brain stimulation (DBS) with electric field steering may avoid areas responsible for side effects. This prospective randomized cross-over trial compared omnidirectional (OS) and directional (DS) subthalamic DBS in 19 patients. Electromyographically measured rigidity was the primary outcome. Motor and non-motor scores were secondary outcomes. There were no significant differences between OS and DS. In the acute setting, both conditions improved motor scores compared to no stimulation. Motor symptoms improved after 3 weeks of OS relative to acute measurements, whereas they worsened under DS. The more ventral the active contact, and the less the motor improvement sweet spot was stimulated, the greater the benefit of DS over OS for executive function. Accurate OS of the dorsal subthalamic nucleus ensures motor and non-motor improvements. While DS can mitigate executive decline stemming from off-target stimulation, it may lead to worse motor outcomes. Larger, long-term studies are needed to confirm these findings. (Registration: subthalamic steering for therapy optimization in Parkinson's Disease ClinicalTrials.gov: NCT03548506, 2018-06-06).